Statistics
Publications
1
Citations
13
H-Index
1
Active since
2020
Affiliations
Samsung (South Korea)(Current)
Bjørn Fehrmann is an author at Samsung (South Korea).
Publications per year
2020–2020
1
1
Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars
Hans C. Ebbers, Bjørn Fehrmann, M. Ottosen et al. · BioDrugs · 2020 · 13 citations · Full text
1–1 of 1